TriSalus Life Sciences, Inc. (TLSI) Stock Competitors & Peer Comparison
See (TLSI) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TLSI | $4.51 | -4.87% | 172.5M | -2.71 | -$1.68 | N/A |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| ABT | $92.58 | -0.15% | 158B | 17.41 | $5.21 | +2.68% |
| ISRG | $403.93 | -0.50% | 140.8B | 41.34 | $9.62 | N/A |
| SYK | $312.10 | -5.57% | 120.7B | 23.51 | $13.39 | +1.11% |
| MDT | $79.36 | -1.94% | 100.2B | 14.15 | $5.53 | +3.62% |
| BSX | $42.87 | -1.41% | 63.4B | 13.75 | $3.10 | N/A |
| EW | $92.00 | +1.34% | 52.5B | 33.77 | $2.70 | N/A |
| RMD | $202.24 | +1.92% | 28.3B | 18.09 | $10.77 | +1.24% |
| DXCM | $68.88 | -1.58% | 26B | 28.90 | $2.33 | N/A |
Stock Comparison
TLSI vs BSX-PA Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, TLSI is priced at $4.51, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, TLSI's ROE is +1.63%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, TLSI is less volatile compared to BSX-PA. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check BSX-PA's competition here
TLSI vs ABT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ABT has a market cap of 158B. Regarding current trading prices, TLSI is priced at $4.51, while ABT trades at $92.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ABT's P/E ratio is 17.41. In terms of profitability, TLSI's ROE is +1.63%, compared to ABT's ROE of +0.12%. Regarding short-term risk, TLSI is more volatile compared to ABT. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check ABT's competition here
TLSI vs ISRG Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ISRG has a market cap of 140.8B. Regarding current trading prices, TLSI is priced at $4.51, while ISRG trades at $403.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ISRG's P/E ratio is 41.34. In terms of profitability, TLSI's ROE is +1.63%, compared to ISRG's ROE of +0.17%. Regarding short-term risk, TLSI is more volatile compared to ISRG. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check ISRG's competition here
TLSI vs SYK Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SYK has a market cap of 120.7B. Regarding current trading prices, TLSI is priced at $4.51, while SYK trades at $312.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SYK's P/E ratio is 23.51. In terms of profitability, TLSI's ROE is +1.63%, compared to SYK's ROE of +0.15%. Regarding short-term risk, TLSI is less volatile compared to SYK. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check SYK's competition here
TLSI vs MDT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, MDT has a market cap of 100.2B. Regarding current trading prices, TLSI is priced at $4.51, while MDT trades at $79.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas MDT's P/E ratio is 14.15. In terms of profitability, TLSI's ROE is +1.63%, compared to MDT's ROE of +0.10%. Regarding short-term risk, TLSI is more volatile compared to MDT. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check MDT's competition here
TLSI vs BSX Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, BSX has a market cap of 63.4B. Regarding current trading prices, TLSI is priced at $4.51, while BSX trades at $42.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas BSX's P/E ratio is 13.75. In terms of profitability, TLSI's ROE is +1.63%, compared to BSX's ROE of +0.15%. Regarding short-term risk, TLSI is more volatile compared to BSX. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check BSX's competition here
TLSI vs EW Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, EW has a market cap of 52.5B. Regarding current trading prices, TLSI is priced at $4.51, while EW trades at $92.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas EW's P/E ratio is 33.77. In terms of profitability, TLSI's ROE is +1.63%, compared to EW's ROE of +0.11%. Regarding short-term risk, TLSI is more volatile compared to EW. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check EW's competition here
TLSI vs RMD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, RMD has a market cap of 28.3B. Regarding current trading prices, TLSI is priced at $4.51, while RMD trades at $202.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas RMD's P/E ratio is 18.09. In terms of profitability, TLSI's ROE is +1.63%, compared to RMD's ROE of +0.24%. Regarding short-term risk, TLSI is less volatile compared to RMD. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check RMD's competition here
TLSI vs DXCM Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, DXCM has a market cap of 26B. Regarding current trading prices, TLSI is priced at $4.51, while DXCM trades at $68.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas DXCM's P/E ratio is 28.90. In terms of profitability, TLSI's ROE is +1.63%, compared to DXCM's ROE of +0.34%. Regarding short-term risk, TLSI is less volatile compared to DXCM. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check DXCM's competition here
TLSI vs ABMD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, TLSI is priced at $4.51, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ABMD's P/E ratio is 65.36. In terms of profitability, TLSI's ROE is +1.63%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, TLSI is more volatile compared to ABMD. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check ABMD's competition here
TLSI vs ZBH Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ZBH has a market cap of 16.6B. Regarding current trading prices, TLSI is priced at $4.51, while ZBH trades at $85.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ZBH's P/E ratio is 10.15. In terms of profitability, TLSI's ROE is +1.63%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, TLSI is less volatile compared to ZBH. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check ZBH's competition here
TLSI vs SWAV Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, TLSI is priced at $4.51, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SWAV's P/E ratio is 78.76. In terms of profitability, TLSI's ROE is +1.63%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, TLSI is more volatile compared to SWAV. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check SWAV's competition here
TLSI vs PEN Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, PEN has a market cap of 12.4B. Regarding current trading prices, TLSI is priced at $4.51, while PEN trades at $316.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas PEN's P/E ratio is 82.44. In terms of profitability, TLSI's ROE is +1.63%, compared to PEN's ROE of +0.12%. Regarding short-term risk, TLSI is more volatile compared to PEN. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check PEN's competition here
TLSI vs SNN Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SNN has a market cap of 12.2B. Regarding current trading prices, TLSI is priced at $4.51, while SNN trades at $28.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SNN's P/E ratio is 15.55. In terms of profitability, TLSI's ROE is +1.63%, compared to SNN's ROE of +0.12%. Regarding short-term risk, TLSI is more volatile compared to SNN. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check SNN's competition here
TLSI vs ALGN Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ALGN has a market cap of 12.1B. Regarding current trading prices, TLSI is priced at $4.51, while ALGN trades at $181.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ALGN's P/E ratio is 15.37. In terms of profitability, TLSI's ROE is +1.63%, compared to ALGN's ROE of +0.11%. Regarding short-term risk, TLSI is less volatile compared to ALGN. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check ALGN's competition here
TLSI vs GMED Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, GMED has a market cap of 10.7B. Regarding current trading prices, TLSI is priced at $4.51, while GMED trades at $76.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas GMED's P/E ratio is 17.80. In terms of profitability, TLSI's ROE is +1.63%, compared to GMED's ROE of +0.13%. Regarding short-term risk, TLSI is less volatile compared to GMED. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check GMED's competition here
TLSI vs PODD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, PODD has a market cap of 10.5B. Regarding current trading prices, TLSI is priced at $4.51, while PODD trades at $160.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas PODD's P/E ratio is 28.30. In terms of profitability, TLSI's ROE is +1.63%, compared to PODD's ROE of +0.21%. Regarding short-term risk, TLSI is less volatile compared to PODD. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check PODD's competition here
TLSI vs MASI Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, TLSI is priced at $4.51, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas MASI's P/E ratio is 44.43. In terms of profitability, TLSI's ROE is +1.63%, compared to MASI's ROE of +0.09%. Regarding short-term risk, TLSI is more volatile compared to MASI. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check MASI's competition here
TLSI vs BRKR Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, BRKR has a market cap of 9.2B. Regarding current trading prices, TLSI is priced at $4.51, while BRKR trades at $61.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas BRKR's P/E ratio is 33.08. In terms of profitability, TLSI's ROE is +1.63%, compared to BRKR's ROE of -0.01%. Regarding short-term risk, TLSI is less volatile compared to BRKR. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check BRKR's competition here
TLSI vs BIO-B Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, BIO-B has a market cap of 8.4B. Regarding current trading prices, TLSI is priced at $4.51, while BIO-B trades at $298.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas BIO-B's P/E ratio is 92.20. In terms of profitability, TLSI's ROE is +1.63%, compared to BIO-B's ROE of +0.02%. Regarding short-term risk, TLSI is less volatile compared to BIO-B. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check BIO-B's competition here
TLSI vs GKOS Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, GKOS has a market cap of 8.2B. Regarding current trading prices, TLSI is priced at $4.51, while GKOS trades at $138.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas GKOS's P/E ratio is -162.44. In terms of profitability, TLSI's ROE is +1.63%, compared to GKOS's ROE of -0.26%. Regarding short-term risk, TLSI is less volatile compared to GKOS. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check GKOS's competition here
TLSI vs BIO Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, BIO has a market cap of 7.9B. Regarding current trading prices, TLSI is priced at $4.51, while BIO trades at $297.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas BIO's P/E ratio is 31.65. In terms of profitability, TLSI's ROE is +1.63%, compared to BIO's ROE of +0.02%. Regarding short-term risk, TLSI is more volatile compared to BIO. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check BIO's competition here
TLSI vs NARI Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, TLSI is priced at $4.51, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas NARI's P/E ratio is -59.24. In terms of profitability, TLSI's ROE is +1.63%, compared to NARI's ROE of -0.00%. Regarding short-term risk, TLSI is more volatile compared to NARI. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check NARI's competition here
TLSI vs LIVN Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, LIVN has a market cap of 4.5B. Regarding current trading prices, TLSI is priced at $4.51, while LIVN trades at $82.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas LIVN's P/E ratio is 20.56. In terms of profitability, TLSI's ROE is +1.63%, compared to LIVN's ROE of +0.09%. Regarding short-term risk, TLSI is more volatile compared to LIVN. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check LIVN's competition here
TLSI vs IRTC Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, IRTC has a market cap of 3.9B. Regarding current trading prices, TLSI is priced at $4.51, while IRTC trades at $125.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas IRTC's P/E ratio is -212.41. In terms of profitability, TLSI's ROE is +1.63%, compared to IRTC's ROE of -0.21%. Regarding short-term risk, TLSI is less volatile compared to IRTC. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check IRTC's competition here
TLSI vs AXNX Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, TLSI is priced at $4.51, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas AXNX's P/E ratio is -709.80. In terms of profitability, TLSI's ROE is +1.63%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, TLSI is more volatile compared to AXNX. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check AXNX's competition here
TLSI vs ITGR Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ITGR has a market cap of 3.2B. Regarding current trading prices, TLSI is priced at $4.51, while ITGR trades at $95.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ITGR's P/E ratio is 14.84. In terms of profitability, TLSI's ROE is +1.63%, compared to ITGR's ROE of +0.08%. Regarding short-term risk, TLSI is less volatile compared to ITGR. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check ITGR's competition here
TLSI vs ESTA Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ESTA has a market cap of 2.5B. Regarding current trading prices, TLSI is priced at $4.51, while ESTA trades at $89.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ESTA's P/E ratio is -59.59. In terms of profitability, TLSI's ROE is +1.63%, compared to ESTA's ROE of -2.26%. Regarding short-term risk, TLSI is less volatile compared to ESTA. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check ESTA's competition here
TLSI vs AXGN Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, TLSI is priced at $4.51, while AXGN trades at $44.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas AXGN's P/E ratio is 121.55. In terms of profitability, TLSI's ROE is +1.63%, compared to AXGN's ROE of -0.21%. Regarding short-term risk, TLSI is less volatile compared to AXGN. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check AXGN's competition here
TLSI vs TMDX Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, TMDX has a market cap of 2.3B. Regarding current trading prices, TLSI is priced at $4.51, while TMDX trades at $69.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas TMDX's P/E ratio is 27.11. In terms of profitability, TLSI's ROE is +1.63%, compared to TMDX's ROE of +0.42%. Regarding short-term risk, TLSI is less volatile compared to TMDX. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check TMDX's competition here
TLSI vs BFLY Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, BFLY has a market cap of 2.2B. Regarding current trading prices, TLSI is priced at $4.51, while BFLY trades at $7.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas BFLY's P/E ratio is -35.15. In terms of profitability, TLSI's ROE is +1.63%, compared to BFLY's ROE of -0.37%. Regarding short-term risk, TLSI is less volatile compared to BFLY. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check BFLY's competition here
TLSI vs NUVA Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, TLSI is priced at $4.51, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas NUVA's P/E ratio is 75.00. In terms of profitability, TLSI's ROE is +1.63%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, TLSI is less volatile compared to NUVA. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check NUVA's competition here
TLSI vs UFPT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, UFPT has a market cap of 2.1B. Regarding current trading prices, TLSI is priced at $4.51, while UFPT trades at $272.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas UFPT's P/E ratio is 27.03. In terms of profitability, TLSI's ROE is +1.63%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, TLSI is less volatile compared to UFPT. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check UFPT's competition here
TLSI vs NVCR Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, NVCR has a market cap of 1.8B. Regarding current trading prices, TLSI is priced at $4.51, while NVCR trades at $15.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas NVCR's P/E ratio is -9.90. In terms of profitability, TLSI's ROE is +1.63%, compared to NVCR's ROE of -0.51%. Regarding short-term risk, TLSI is less volatile compared to NVCR. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check NVCR's competition here
TLSI vs AHCO Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, AHCO has a market cap of 1.4B. Regarding current trading prices, TLSI is priced at $4.51, while AHCO trades at $10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas AHCO's P/E ratio is 23.68. In terms of profitability, TLSI's ROE is +1.63%, compared to AHCO's ROE of -0.05%. Regarding short-term risk, TLSI is less volatile compared to AHCO. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check AHCO's competition here
TLSI vs IART Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, IART has a market cap of 1.4B. Regarding current trading prices, TLSI is priced at $4.51, while IART trades at $18.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas IART's P/E ratio is 7.61. In terms of profitability, TLSI's ROE is +1.63%, compared to IART's ROE of -0.48%. Regarding short-term risk, TLSI is less volatile compared to IART. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check IART's competition here
TLSI vs ATEC Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ATEC has a market cap of 1.3B. Regarding current trading prices, TLSI is priced at $4.51, while ATEC trades at $8.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ATEC's P/E ratio is -78.64. In terms of profitability, TLSI's ROE is +1.63%, compared to ATEC's ROE of -4.43%. Regarding short-term risk, TLSI is less volatile compared to ATEC. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check ATEC's competition here
TLSI vs HSKA Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, TLSI is priced at $4.51, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas HSKA's P/E ratio is -62.49. In terms of profitability, TLSI's ROE is +1.63%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, TLSI is more volatile compared to HSKA. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check HSKA's competition here
TLSI vs INSP Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, INSP has a market cap of 1.3B. Regarding current trading prices, TLSI is priced at $4.51, while INSP trades at $45.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas INSP's P/E ratio is 17.29. In terms of profitability, TLSI's ROE is +1.63%, compared to INSP's ROE of +0.18%. Regarding short-term risk, TLSI is less volatile compared to INSP. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check INSP's competition here
TLSI vs PRCT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, PRCT has a market cap of 1.3B. Regarding current trading prices, TLSI is priced at $4.51, while PRCT trades at $23.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas PRCT's P/E ratio is -12.41. In terms of profitability, TLSI's ROE is +1.63%, compared to PRCT's ROE of -0.28%. Regarding short-term risk, TLSI is less volatile compared to PRCT. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check PRCT's competition here
TLSI vs IRMD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, IRMD has a market cap of 1.2B. Regarding current trading prices, TLSI is priced at $4.51, while IRMD trades at $98.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas IRMD's P/E ratio is 48.02. In terms of profitability, TLSI's ROE is +1.63%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, TLSI is less volatile compared to IRMD. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check IRMD's competition here
TLSI vs ENOV Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ENOV has a market cap of 1.2B. Regarding current trading prices, TLSI is priced at $4.51, while ENOV trades at $20.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ENOV's P/E ratio is 6.12. In terms of profitability, TLSI's ROE is +1.63%, compared to ENOV's ROE of -0.60%. Regarding short-term risk, TLSI is less volatile compared to ENOV. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check ENOV's competition here
TLSI vs AVNS Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, TLSI is priced at $4.51, while AVNS trades at $24.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas AVNS's P/E ratio is 27.65. In terms of profitability, TLSI's ROE is +1.63%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, TLSI is more volatile compared to AVNS. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check AVNS's competition here
TLSI vs SILK Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, TLSI is priced at $4.51, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SILK's P/E ratio is -18.96. In terms of profitability, TLSI's ROE is +1.63%, compared to SILK's ROE of -0.35%. Regarding short-term risk, TLSI is more volatile compared to SILK. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check SILK's competition here
TLSI vs FNA Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, TLSI is priced at $4.51, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas FNA's P/E ratio is -19.83. In terms of profitability, TLSI's ROE is +1.63%, compared to FNA's ROE of -0.35%. Regarding short-term risk, TLSI is more volatile compared to FNA. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check FNA's competition here
TLSI vs AORT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, AORT has a market cap of 1.1B. Regarding current trading prices, TLSI is priced at $4.51, while AORT trades at $23.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas AORT's P/E ratio is 34.63. In terms of profitability, TLSI's ROE is +1.63%, compared to AORT's ROE of +0.03%. Regarding short-term risk, TLSI is less volatile compared to AORT. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check AORT's competition here
TLSI vs LMRI Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, TLSI is priced at $4.51, while LMRI trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas LMRI's P/E ratio is -21.95. In terms of profitability, TLSI's ROE is +1.63%, compared to LMRI's ROE of -0.14%. Regarding short-term risk, TLSI is less volatile compared to LMRI. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check LMRI's competition here
TLSI vs TNDM Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, TNDM has a market cap of 1B. Regarding current trading prices, TLSI is priced at $4.51, while TNDM trades at $15.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas TNDM's P/E ratio is -13.72. In terms of profitability, TLSI's ROE is +1.63%, compared to TNDM's ROE of -0.68%. Regarding short-term risk, TLSI is less volatile compared to TNDM. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check TNDM's competition here
TLSI vs CNMD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, CNMD has a market cap of 986.4M. Regarding current trading prices, TLSI is priced at $4.51, while CNMD trades at $32.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas CNMD's P/E ratio is 7.20. In terms of profitability, TLSI's ROE is +1.63%, compared to CNMD's ROE of +0.05%. Regarding short-term risk, TLSI is less volatile compared to CNMD. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check CNMD's competition here
TLSI vs CSII Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, TLSI is priced at $4.51, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas CSII's P/E ratio is -20.83. In terms of profitability, TLSI's ROE is +1.63%, compared to CSII's ROE of -0.14%. Regarding short-term risk, TLSI is more volatile compared to CSII. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check CSII's competition here
TLSI vs INMD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, INMD has a market cap of 840.4M. Regarding current trading prices, TLSI is priced at $4.51, while INMD trades at $14.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas INMD's P/E ratio is 9.37. In terms of profitability, TLSI's ROE is +1.63%, compared to INMD's ROE of +0.13%. Regarding short-term risk, TLSI is less volatile compared to INMD. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check INMD's competition here
TLSI vs SSII Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SSII has a market cap of 808.5M. Regarding current trading prices, TLSI is priced at $4.51, while SSII trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SSII's P/E ratio is -78.80. In terms of profitability, TLSI's ROE is +1.63%, compared to SSII's ROE of -0.23%. Regarding short-term risk, TLSI is less volatile compared to SSII. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check SSII's competition here
TLSI vs CBLL Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, CBLL has a market cap of 738M. Regarding current trading prices, TLSI is priced at $4.51, while CBLL trades at $19.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas CBLL's P/E ratio is -11.93. In terms of profitability, TLSI's ROE is +1.63%, compared to CBLL's ROE of -0.38%. Regarding short-term risk, TLSI is less volatile compared to CBLL. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check CBLL's competition here
TLSI vs CRY Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, CRY has a market cap of 725.1M. Regarding current trading prices, TLSI is priced at $4.51, while CRY trades at $17.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas CRY's P/E ratio is 425.71. In terms of profitability, TLSI's ROE is +1.63%, compared to CRY's ROE of +0.03%. Regarding short-term risk, TLSI is less volatile compared to CRY. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check CRY's competition here
TLSI vs SIBN Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SIBN has a market cap of 723.8M. Regarding current trading prices, TLSI is priced at $4.51, while SIBN trades at $16.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SIBN's P/E ratio is -41.85. In terms of profitability, TLSI's ROE is +1.63%, compared to SIBN's ROE of -0.10%. Regarding short-term risk, TLSI is less volatile compared to SIBN. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check SIBN's competition here
TLSI vs TCMD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, TCMD has a market cap of 671.7M. Regarding current trading prices, TLSI is priced at $4.51, while TCMD trades at $30.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas TCMD's P/E ratio is 33.84. In terms of profitability, TLSI's ROE is +1.63%, compared to TCMD's ROE of +0.10%. Regarding short-term risk, TLSI is less volatile compared to TCMD. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check TCMD's competition here
TLSI vs BVS Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, BVS has a market cap of 639.5M. Regarding current trading prices, TLSI is priced at $4.51, while BVS trades at $9.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas BVS's P/E ratio is 12.59. In terms of profitability, TLSI's ROE is +1.63%, compared to BVS's ROE of +0.16%. Regarding short-term risk, TLSI is less volatile compared to BVS. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check BVS's competition here
TLSI vs SRDX Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, TLSI is priced at $4.51, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SRDX's P/E ratio is -34.66. In terms of profitability, TLSI's ROE is +1.63%, compared to SRDX's ROE of -0.13%. Regarding short-term risk, TLSI is more volatile compared to SRDX. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check SRDX's competition here
TLSI vs BWAY Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, BWAY has a market cap of 608.3M. Regarding current trading prices, TLSI is priced at $4.51, while BWAY trades at $15.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas BWAY's P/E ratio is 39.40. In terms of profitability, TLSI's ROE is +1.63%, compared to BWAY's ROE of +0.12%. Regarding short-term risk, TLSI is less volatile compared to BWAY. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check BWAY's competition here
TLSI vs CERS Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, CERS has a market cap of 585.1M. Regarding current trading prices, TLSI is priced at $4.51, while CERS trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas CERS's P/E ratio is -58.28. In terms of profitability, TLSI's ROE is +1.63%, compared to CERS's ROE of -0.15%. Regarding short-term risk, TLSI is less volatile compared to CERS. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check CERS's competition here
TLSI vs APEN Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, TLSI is priced at $4.51, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas APEN's P/E ratio is -9.43. In terms of profitability, TLSI's ROE is +1.63%, compared to APEN's ROE of -0.85%. Regarding short-term risk, TLSI is more volatile compared to APEN. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check APEN's competition here
TLSI vs CTKB Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, CTKB has a market cap of 572.1M. Regarding current trading prices, TLSI is priced at $4.51, while CTKB trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas CTKB's P/E ratio is -34.08. In terms of profitability, TLSI's ROE is +1.63%, compared to CTKB's ROE of -0.21%. Regarding short-term risk, TLSI is less volatile compared to CTKB. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check CTKB's competition here
TLSI vs NPCE Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, NPCE has a market cap of 541.7M. Regarding current trading prices, TLSI is priced at $4.51, while NPCE trades at $15.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas NPCE's P/E ratio is -27.40. In terms of profitability, TLSI's ROE is +1.63%, compared to NPCE's ROE of -1.21%. Regarding short-term risk, TLSI is less volatile compared to NPCE. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check NPCE's competition here
TLSI vs ZIMV Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, TLSI is priced at $4.51, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, TLSI's ROE is +1.63%, compared to ZIMV's ROE of -0.04%. Regarding short-term risk, TLSI is more volatile compared to ZIMV. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check ZIMV's competition here
TLSI vs CLPT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, CLPT has a market cap of 535M. Regarding current trading prices, TLSI is priced at $4.51, while CLPT trades at $18.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas CLPT's P/E ratio is -17.66. In terms of profitability, TLSI's ROE is +1.63%, compared to CLPT's ROE of -1.41%. Regarding short-term risk, TLSI is less volatile compared to CLPT. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check CLPT's competition here
TLSI vs PACB Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, PACB has a market cap of 521.8M. Regarding current trading prices, TLSI is priced at $4.51, while PACB trades at $1.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas PACB's P/E ratio is -3.43. In terms of profitability, TLSI's ROE is +1.63%, compared to PACB's ROE of -4.88%. Regarding short-term risk, TLSI is less volatile compared to PACB. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check PACB's competition here
TLSI vs KIDS Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, KIDS has a market cap of 491.4M. Regarding current trading prices, TLSI is priced at $4.51, while KIDS trades at $19.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas KIDS's P/E ratio is -18.57. In terms of profitability, TLSI's ROE is +1.63%, compared to KIDS's ROE of -0.11%. Regarding short-term risk, TLSI is less volatile compared to KIDS. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check KIDS's competition here
TLSI vs VREX Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, VREX has a market cap of 439.1M. Regarding current trading prices, TLSI is priced at $4.51, while VREX trades at $10.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas VREX's P/E ratio is 10.98. In terms of profitability, TLSI's ROE is +1.63%, compared to VREX's ROE of -0.18%. Regarding short-term risk, TLSI is more volatile compared to VREX. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check VREX's competition here
TLSI vs DCTH Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, DCTH has a market cap of 434.6M. Regarding current trading prices, TLSI is priced at $4.51, while DCTH trades at $12.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas DCTH's P/E ratio is 1259.00. In terms of profitability, TLSI's ROE is +1.63%, compared to DCTH's ROE of +0.01%. Regarding short-term risk, TLSI is less volatile compared to DCTH. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check DCTH's competition here
TLSI vs OFIX Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, OFIX has a market cap of 369.5M. Regarding current trading prices, TLSI is priced at $4.51, while OFIX trades at $9.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas OFIX's P/E ratio is -37.23. In terms of profitability, TLSI's ROE is +1.63%, compared to OFIX's ROE of -0.13%. Regarding short-term risk, TLSI is less volatile compared to OFIX. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check OFIX's competition here
TLSI vs AVR Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, AVR has a market cap of 362.4M. Regarding current trading prices, TLSI is priced at $4.51, while AVR trades at $10.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas AVR's P/E ratio is -4.42. In terms of profitability, TLSI's ROE is +1.63%, compared to AVR's ROE of -1.24%. Regarding short-term risk, TLSI is less volatile compared to AVR. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check AVR's competition here
TLSI vs ELMD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ELMD has a market cap of 346.9M. Regarding current trading prices, TLSI is priced at $4.51, while ELMD trades at $44.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ELMD's P/E ratio is 35.81. In terms of profitability, TLSI's ROE is +1.63%, compared to ELMD's ROE of +0.22%. Regarding short-term risk, TLSI is less volatile compared to ELMD. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check ELMD's competition here
TLSI vs SMLR Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, TLSI is priced at $4.51, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SMLR's P/E ratio is 3.92. In terms of profitability, TLSI's ROE is +1.63%, compared to SMLR's ROE of +0.16%. Regarding short-term risk, TLSI is more volatile compared to SMLR. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check SMLR's competition here
TLSI vs SGHT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SGHT has a market cap of 294.9M. Regarding current trading prices, TLSI is priced at $4.51, while SGHT trades at $5.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SGHT's P/E ratio is -8.60. In terms of profitability, TLSI's ROE is +1.63%, compared to SGHT's ROE of -0.59%. Regarding short-term risk, TLSI is less volatile compared to SGHT. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check SGHT's competition here
TLSI vs CATX Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, CATX has a market cap of 262.7M. Regarding current trading prices, TLSI is priced at $4.51, while CATX trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas CATX's P/E ratio is -2.41. In terms of profitability, TLSI's ROE is +1.63%, compared to CATX's ROE of -0.42%. Regarding short-term risk, TLSI is less volatile compared to CATX. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check CATX's competition here
TLSI vs TMCI Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, TMCI has a market cap of 258.2M. Regarding current trading prices, TLSI is priced at $4.51, while TMCI trades at $4.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas TMCI's P/E ratio is -4.23. In terms of profitability, TLSI's ROE is +1.63%, compared to TMCI's ROE of -0.69%. Regarding short-term risk, TLSI is less volatile compared to TMCI. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check TMCI's competition here
TLSI vs PMI Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, PMI has a market cap of 255.2M. Regarding current trading prices, TLSI is priced at $4.51, while PMI trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas PMI's P/E ratio is -0.14. In terms of profitability, TLSI's ROE is +1.63%, compared to PMI's ROE of +4.99%. Regarding short-term risk, TLSI is less volatile compared to PMI. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check PMI's competition here
TLSI vs MGRM Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, TLSI is priced at $4.51, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas MGRM's P/E ratio is -12.00. In terms of profitability, TLSI's ROE is +1.63%, compared to MGRM's ROE of -1.11%. Regarding short-term risk, TLSI is more volatile compared to MGRM. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check MGRM's competition here
TLSI vs SENS Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, SENS has a market cap of 237.4M. Regarding current trading prices, TLSI is priced at $4.51, while SENS trades at $5.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas SENS's P/E ratio is -2.84. In terms of profitability, TLSI's ROE is +1.63%, compared to SENS's ROE of -1.30%. Regarding short-term risk, TLSI is less volatile compared to SENS. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check SENS's competition here
TLSI vs NVRO Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, TLSI is priced at $4.51, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas NVRO's P/E ratio is -1.91. In terms of profitability, TLSI's ROE is +1.63%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, TLSI is more volatile compared to NVRO. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check NVRO's competition here
TLSI vs EYES Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, EYES has a market cap of 210M. Regarding current trading prices, TLSI is priced at $4.51, while EYES trades at $4.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas EYES's P/E ratio is N/A. In terms of profitability, TLSI's ROE is +1.63%, compared to EYES's ROE of -2.64%. Regarding short-term risk, TLSI is less volatile compared to EYES. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check EYES's competition here
TLSI vs QTRX Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, QTRX has a market cap of 203.5M. Regarding current trading prices, TLSI is priced at $4.51, while QTRX trades at $4.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas QTRX's P/E ratio is -2.70. In terms of profitability, TLSI's ROE is +1.63%, compared to QTRX's ROE of -0.35%. Regarding short-term risk, TLSI is less volatile compared to QTRX. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check QTRX's competition here
TLSI vs PROF Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, PROF has a market cap of 201.2M. Regarding current trading prices, TLSI is priced at $4.51, while PROF trades at $6.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas PROF's P/E ratio is -5.36. In terms of profitability, TLSI's ROE is +1.63%, compared to PROF's ROE of -0.70%. Regarding short-term risk, TLSI is less volatile compared to PROF. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check PROF's competition here
TLSI vs RXST Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, RXST has a market cap of 199.5M. Regarding current trading prices, TLSI is priced at $4.51, while RXST trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas RXST's P/E ratio is -6.69. In terms of profitability, TLSI's ROE is +1.63%, compared to RXST's ROE of -0.17%. Regarding short-term risk, TLSI is less volatile compared to RXST. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check RXST's competition here
TLSI vs ANIK Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ANIK has a market cap of 194.7M. Regarding current trading prices, TLSI is priced at $4.51, while ANIK trades at $15.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ANIK's P/E ratio is 29.86. In terms of profitability, TLSI's ROE is +1.63%, compared to ANIK's ROE of -0.08%. Regarding short-term risk, TLSI is less volatile compared to ANIK. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check ANIK's competition here
TLSI vs FOCL Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, FOCL has a market cap of 194.2M. Regarding current trading prices, TLSI is priced at $4.51, while FOCL trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas FOCL's P/E ratio is -10.47. In terms of profitability, TLSI's ROE is +1.63%, compared to FOCL's ROE of -1.38%. Regarding short-term risk, TLSI is more volatile compared to FOCL. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check FOCL's competition here
TLSI vs BSGM Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, TLSI is priced at $4.51, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas BSGM's P/E ratio is -5.81. In terms of profitability, TLSI's ROE is +1.63%, compared to BSGM's ROE of +17.60%. Regarding short-term risk, TLSI is less volatile compared to BSGM. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check BSGM's competition here
TLSI vs MDGS Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, TLSI is priced at $4.51, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas MDGS's P/E ratio is -0.27. In terms of profitability, TLSI's ROE is +1.63%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, TLSI is less volatile compared to MDGS. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check MDGS's competition here
TLSI vs INGN Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, INGN has a market cap of 174.6M. Regarding current trading prices, TLSI is priced at $4.51, while INGN trades at $6.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas INGN's P/E ratio is -7.09. In terms of profitability, TLSI's ROE is +1.63%, compared to INGN's ROE of -0.13%. Regarding short-term risk, TLSI is less volatile compared to INGN. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check INGN's competition here
TLSI vs QIPT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, TLSI is priced at $4.51, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas QIPT's P/E ratio is -15.87. In terms of profitability, TLSI's ROE is +1.63%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, TLSI is more volatile compared to QIPT. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check QIPT's competition here
TLSI vs CVRX Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, CVRX has a market cap of 136.4M. Regarding current trading prices, TLSI is priced at $4.51, while CVRX trades at $5.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas CVRX's P/E ratio is -2.54. In terms of profitability, TLSI's ROE is +1.63%, compared to CVRX's ROE of -1.21%. Regarding short-term risk, TLSI is less volatile compared to CVRX. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check CVRX's competition here
TLSI vs QTI Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, QTI has a market cap of 110.4M. Regarding current trading prices, TLSI is priced at $4.51, while QTI trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas QTI's P/E ratio is -5.99. In terms of profitability, TLSI's ROE is +1.63%, compared to QTI's ROE of -63.31%. Regarding short-term risk, TLSI is more volatile compared to QTI. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check QTI's competition here
TLSI vs LUCD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, LUCD has a market cap of 109.5M. Regarding current trading prices, TLSI is priced at $4.51, while LUCD trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas LUCD's P/E ratio is -2.89. In terms of profitability, TLSI's ROE is +1.63%, compared to LUCD's ROE of -3.70%. Regarding short-term risk, TLSI is less volatile compared to LUCD. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check LUCD's competition here
TLSI vs ICAD Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, TLSI is priced at $4.51, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ICAD's P/E ratio is -20.37. In terms of profitability, TLSI's ROE is +1.63%, compared to ICAD's ROE of -0.06%. Regarding short-term risk, TLSI is more volatile compared to ICAD. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check ICAD's competition here
TLSI vs OWLT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, OWLT has a market cap of 103.9M. Regarding current trading prices, TLSI is priced at $4.51, while OWLT trades at $5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas OWLT's P/E ratio is -41.00. In terms of profitability, TLSI's ROE is +1.63%, compared to OWLT's ROE of +11.36%. Regarding short-term risk, TLSI is less volatile compared to OWLT. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check OWLT's competition here
TLSI vs RCEL Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, RCEL has a market cap of 102.6M. Regarding current trading prices, TLSI is priced at $4.51, while RCEL trades at $4.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas RCEL's P/E ratio is -2.63. In terms of profitability, TLSI's ROE is +1.63%, compared to RCEL's ROE of +3.05%. Regarding short-term risk, TLSI is less volatile compared to RCEL. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check RCEL's competition here
TLSI vs HJLI Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, TLSI is priced at $4.51, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas HJLI's P/E ratio is N/A. In terms of profitability, TLSI's ROE is +1.63%, compared to HJLI's ROE of -0.66%. Regarding short-term risk, TLSI is less volatile compared to HJLI. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check HJLI's competition here
TLSI vs HSDT Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, HSDT has a market cap of 96.3M. Regarding current trading prices, TLSI is priced at $4.51, while HSDT trades at $1.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas HSDT's P/E ratio is -0.02. In terms of profitability, TLSI's ROE is +1.63%, compared to HSDT's ROE of -1.55%. Regarding short-term risk, TLSI is less volatile compared to HSDT. This indicates potentially lower risk in terms of short-term price fluctuations for TLSI.Check HSDT's competition here
TLSI vs ASXC Comparison July 2026
TLSI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TLSI stands at 172.5M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, TLSI is priced at $4.51, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TLSI currently has a P/E ratio of -2.71, whereas ASXC's P/E ratio is -1.12. In terms of profitability, TLSI's ROE is +1.63%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, TLSI is more volatile compared to ASXC. This indicates potentially higher risk in terms of short-term price fluctuations for TLSI.Check ASXC's competition here